Risk assessment with gut microbiome and metabolite markers in NAFLD development

Accession: MTBLS2615
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling; mass spectrometry; Liquid Chromatography MS - negative - reverse phase
Organism: unspec
Size (indexed): 326.0 MB (341856521 bytes)
Downloaded bytes: 2.0 MB (2097499 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
MTBLS2615.announcement.json114.8 KB3e19e7d9102d4895…
MTBLS2615.mhd.json1.6 MB7da11e935332e9ff…
a_MTBLS2615_LC-MS_negative_reverse-phase_metabolite_profiling.txt111.5 KB0ed71cf66cc5185b…
i_Investigation.txt15.6 KBfdebcbeb1359d29f…
m_MTBLS2615_LC-MS_negative_reverse-phase_metabolite_profiling_v2_maf.tsv137.2 KB90a1e3745030ccb0…
s_MTBLS2615.txt51.1 KB364e6511570e8919…

Index note: public study (ISA-Tab+MAF)

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T19:14:26Z.

About this dataset

This metabolite profiling; mass spectrometry; Liquid Chromatography MS - negative - reverse phase dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.